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Giovanni Longo, MD,* Yusuke Fujino, MD,x Piera Capranzano, MD, PHD,*z Corrado Tamburino, MD, PHD*zR ecently described, metallic drug-eluting stentlongitudinal distortion is a mechanical phe-nomenon that leads to stent compression
and strut separation (“pseudofracture”) during per-
cutaneous coronary intervention (1). Conversely, bio-
resorbable vascular scaffolds (BVS; Absorb, Abbott
Vascular, Santa Clara, California) implantation may
be associated with scaffold elongation (i.e., longitudi-
nal stretching), but the mechanisms associated with
this phenomenon are still not completely elucidated
(2). Herein, we report 2 representative cases that
further reﬁne the description of its mechanisms.
Two patients underwent uneventful implantation
of BVS because of unstable angina. Optical coherence
tomography (OCT) (Ilumien, St. Jude Medical, Saint
Paul, Minnesota) assessments were performed after
BVS deployment. None of the cases underwent bal-
loon post-dilation. One patient in whom a 3.0 
18-mm BVS was implanted at 16 atm revealed a BVS
length by OCT of 20.6 mm (14.4% longer than pre-
dicted by nominal length); in addition, this patient
demonstrated reduced thickness of BVS struts (mean
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Institute, University Hospitals, Case Medical Center, Cleveland, Ohio; zExcell
Catania, Italy; and the xNew Tokyo Hospital, Chiba, Japan. Dr. Attizzani has r
Medical, Inc. Dr. Tamburino has received speaker honoraria from Abbott Vas
no relationships relevant to the contents of this paper to disclose. Drs. Ohn
Manuscript received August 22, 2014; revised manuscript received Octoberother patient had a 3.5  18-mm BVS implanted
at 10 atm, and no elongation compared with the
predicted length was revealed by OCT evaluation
(i.e., OCT measured length 18 mm); furthermore, the
thickness of the struts was larger compared with the
elongated scaffold (mean strut thickness 154  2 mm,
similar to the value provided by the manufacturer
of 156 mm) (Figure 1).
Although elongation occurred without compro-
mising scaffold strut integrity in this early experience
(i.e., neither disruption nor fracture were revealed),
we hypothesized that BVS longitudinal stretching
could be associated with a reduction in scaffold
strut thickness, as well as with alteration in the
scaffold cell conformation, as herewith demonstrated
by high-resolution intravascular imaging. Although
we acknowledge that the clinical impact of elongation
and alteration in scaffold cell conformation deserves
further investigation, we speculate that it might
affect the following scenarios during BVS implanta-
tion: 1) bifurcations (i.e., impairment of side branch
access); 2) ostial lesions (i.e., protruding the scaffold
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FIGURE 1 2- and 3-D OCT Imaging of Elongated and Nonelongated BVS
In A, one can depict the elongated (compared with nominal length) scaffold, whereas axial compression (mean strut thickness 131  7 mm)
of the struts compared with the nonelongated scaffold is revealed in B and C. Notably, 3-dimensional (3-D) reconstruction (D) demonstrates
alteration in scaffold cell conformation compared with the 3-D reconstruction of nonelongated scaffold (H). The nonelongated scaffold is
demonstrated in E, whereas F and G show noncompressed struts (i.e., mean strut thickness 154  2 mm). OCT ¼ optical coherence tomography.
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e36without intention to do so); 3) overlapping (i.e., per-
forming longer overlapping than expected); and 4)
eventually leading to longitudinal geographic miss
(i.e., landing the scaffold in a diseased region distal or
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